1. Viral factors and outcome of chronic hepatitis B revisited

   • François Habersetzer
   • Rémy Moenne-Loccoz
   • Thomas F. Baumert

   Editorial 11 September 2013 Pages: 945 - 947

2. The prediction of immunological dysfunction during antiviral therapy for HCV after liver transplantation: can we improve outcomes?

   • Ji-Yuan Zhang
   • Yuan-Yuan Li
   • Fu-Sheng Wang

   Editorial 17 October 2013 Pages: 948 - 950

3. Human parenchymal and non-parenchymal liver cell isolation, culture and characterization

   • Georg Damm
   • Elisa Pfeiffer
   • Thomas S. Weiss

   Review Article 10 October 2013 Pages: 951 - 958

   

4. Angiogenesis in liver regeneration and fibrosis: “a double-edged sword”

   • Savneet Kaur
   • K. Anita

   Review Article 09 November 2013 Pages: 959 - 968

   

5. HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients

   • Turyadi
   • Meta Dewi Thedja
   • David Handojo Muljono

   Original Article 23 May 2013 Pages: 969 - 980

   

6. Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B

   • Mamun Al-Mahtab
   • Sheikh Mohammad Fazle Akbar
   • Salimur Rahman

   Original Article 09 November 2013 Pages: 981 - 989

   

7. Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival

   • Pratima Sharma
   • Amy Hosmer
   • Anna S. Lok

   Original Article 25 April 2013 Pages: 990 - 999

   

8. The virological response in Koreans infected with HCV genotype 1 did not differ between groups treated with a full dose or reduced dose (≥80 % full dose) of peginterferon alfa-2a: a prospective randomized multicenter trial

   • Jung Hyun Kwon
   • Si Hyun Bae
   • Hyeon Woo Yim

   Original Article 23 October 2013 Pages: 1000 - 1009

   

9. Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance

   • Dong Hyun Sinn
   • Jieun Yi
   • Byung Chul Yoo

   Original Article 27 July 2013 Pages: 1010 - 1018

   

10. Familial clustering of hepatocellular carcinoma in HBsAg-positive patients in the United States

    • Myron John Tong
    • Thatcher Thi Huynh
    • Surachate Siripongsakun

    Original Article 17 July 2013 Pages: 1019 - 1029

    

11. Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan

    • Taro Shimada
    • Hitoshi Maruyama
    • Osamu Yokosuka

    Original Article 28 August 2013 Pages: 1030 - 1039

    

12. Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study

    • Ruben Hernaez
    • Hsin-Chieh Yeh
    • Jeanne M. Clark

    Original Article 17 October 2013 Pages: 1040 - 1049

    

13. Circulating free DNA in the progression of liver damage to hepatocellular carcinoma

    • Marika Piciocchi
    • Romilda Cardin
    • Fabio Farinati

    Original Article 02 November 2013 Pages: 1050 - 1057

    

14. Value of the APASL severity score in patients with acute variceal bleeding: a single center experience

    • Go Heun Kim
    • Jeong Han Kim
    • Chang Hong Lee

    Original Article 29 August 2013 Pages: 1058 - 1064

    

15. Hedgehog signaling influences gender-specific response of liver to radiation in mice

    • Sihyung Wang
    • Keumju Lee
    • Youngmi Jung

    Original Article 27 July 2013 Pages: 1065 - 1074

    

16. Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation

    • Silvia Gaia
    • Antonella Olivero
    • Corrado Tarella

    Original Article 11 October 2013 Pages: 1075 - 1083

    

17. Hepatocytes of cirrhotic rat liver accumulate glycogen more slowly than normal ones

    • Natalia N. Bezborodkina
    • Sergey V. Okovity
    • Boris N. Kudryavtsev

    Original Article 23 July 2013 Pages: 1084 - 1090